These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 18586538)
1. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain. Hamed SA; Fida NM; Hamed EA Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538 [TBL] [Abstract][Full Text] [Related]
2. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy. Kim JY; Lee HW Epilepsia; 2007 Jul; 48(7):1366-70. PubMed ID: 17565596 [TBL] [Abstract][Full Text] [Related]
3. Circulating levels of allopregnanolone, a neuroactive steroid, and leptin during treatment with valproic acid in children with epilepsy. Grosso S; Luisi S; Mostardini R; Matera M; Barlocco EG; Casarosa E; Balestri P; Petraglia F Neuroendocrinology; 2011; 93(3):159-64. PubMed ID: 20980729 [TBL] [Abstract][Full Text] [Related]
4. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy. Pylvänen V; Pakarinen A; Knip M; Isojärvi J Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693 [TBL] [Abstract][Full Text] [Related]
5. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children. Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247 [TBL] [Abstract][Full Text] [Related]
6. Metabolic and endocrine effects of valproic acid chronic treatment. Belcastro V; D'Egidio C; Striano P; Verrotti A Epilepsy Res; 2013 Nov; 107(1-2):1-8. PubMed ID: 24076030 [TBL] [Abstract][Full Text] [Related]
7. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. Zeng K; Wang X; Xi Z; Yan Y Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075 [TBL] [Abstract][Full Text] [Related]
8. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children. Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A Seizure; 2018 May; 58():90-95. PubMed ID: 29679911 [TBL] [Abstract][Full Text] [Related]
9. Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study. Sidhu HS; Srinivas R; Sadhotra A Seizure; 2017 May; 48():15-21. PubMed ID: 28365440 [TBL] [Abstract][Full Text] [Related]
10. Valproate sodium enhances body weight gain in patients with childhood epilepsy: a pathogenic mechanisms and open-label clinical trial of behavior therapy. Kanemura H; Sano F; Maeda Y; Sugita K; Aihara M Seizure; 2012 Sep; 21(7):496-500. PubMed ID: 22694920 [TBL] [Abstract][Full Text] [Related]
11. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257 [TBL] [Abstract][Full Text] [Related]
12. Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy. Luef G; Abraham I; Hoppichler F; Trinka E; Unterberger I; Bauer G; Lechleitner M Metabolism; 2002 Oct; 51(10):1274-8. PubMed ID: 12370846 [TBL] [Abstract][Full Text] [Related]
13. Weight and fat distribution in patients taking valproate: a valproate-discordant gender-matched twin and sibling pair study. Petty SJ; Kantor S; Lawrence KM; Berkovic SF; Collins M; Hill KD; Makovey J; Sambrook PN; O'Brien TJ; Wark JD Epilepsia; 2014 Oct; 55(10):1551-7. PubMed ID: 25124647 [TBL] [Abstract][Full Text] [Related]
14. The role of ghrelin in weight gain and growth in epileptic children using valproate. Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556 [TBL] [Abstract][Full Text] [Related]
15. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women. Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666 [TBL] [Abstract][Full Text] [Related]
16. Valproate, weight gain and carbohydrate craving: a gender study. El-Khatib F; Rauchenzauner M; Lechleitner M; Hoppichler F; Naser A; Waldmann M; Trinka E; Unterberger I; Bauer G; Luef GJ Seizure; 2007 Apr; 16(3):226-32. PubMed ID: 17210261 [TBL] [Abstract][Full Text] [Related]
17. Fasting serum insulin and lipid levels in men with epilepsy. Pylvänen V; Knip M; Pakarinen AJ; Turkka J; Kotila M; Rättyä J; Myllylä VV; Isojärvi JI Neurology; 2003 Feb; 60(4):571-4. PubMed ID: 12601094 [TBL] [Abstract][Full Text] [Related]
18. Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment. Zuberi NA; Baig M; Bano S; Batool Z; Haider S; Perveen T Neurosciences (Riyadh); 2017 Apr; 22(2):114-118. PubMed ID: 28416782 [TBL] [Abstract][Full Text] [Related]
19. Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation. Mikkonen K; Knip M; Pakarinen AJ; Lanning P; Isojärvi JI; Vainionpää LK Epilepsia; 2005 Jul; 46(7):1114-20. PubMed ID: 16026564 [TBL] [Abstract][Full Text] [Related]
20. Valproate-induced insulin resistance and obesity in children. Verrotti A; la Torre R; Trotta D; Mohn A; Chiarelli F Horm Res; 2009; 71(3):125-31. PubMed ID: 19188736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]